← Leaderboards
Dale Murray Needham
Johns Hopkins University
$11,296,966
Attributed
$20,016,231
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,016,231 · 9
By mechanism
R01$10,998,858 · 5
R24$5,391,763 · 1
R42$2,275,472 · 1
U01$1,133,343 · 1
R21$216,795 · 1
Top collaborators
- Renee D Stapleton9 shared
- Martin Bruce Brodsky5 shared
- Samuel Morris Brown5 shared
- Daren Keith Heyland5 shared
- Ramona O Hopkins5 shared
- Vinciya Pandian5 shared
- Catherine Lee Hough4 shared
- Christina Eleanor Barkauskas3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Martin Bruce Brodsky$1,903,108
- Mahendra Damarla$6,424,136
- Richard Holubkov$11,946,832
- James H Finigan$2,677,363
- Viswanathan Natarajan$24,234,784
Others in their field
Top investigators on “Intensive Care Units”
- Abhik Das · Research Triangle Institute$55,434,997
- Adrian Hernandez · Duke University$50,769,596
- Marco Pahor · Wake Forest University Health Sciences$42,997,184
- Jonathan Michael Dean · University Of Utah$42,315,983
- Richard T D'aquila · Massachusetts General Hospital$27,454,413
- Robert M Califf · Duke University$23,964,897
Research focus
Intensive Care UnitsMechanical VentilationCritical CarePhysical FunctionReportingFollow-UpEnrollmentEvaluationSurvivorsIncidenceMorbidity - Disease RateBaseSiteAmericanImpairmentProspectiveCohortCritical IllnessDesignCessation Of LifeFoundationsAdult Respiratory Distress SyndromeAcuteMuscle Weakness
Grant awards (34)
The Intermountain West-Atlantic Center (InterACT) for the APS Phenotyping Consortium$605,111
U01 · FY2025 · HL
The Intermountain West-Atlantic Center (InterACT) for the APS Phenotyping Consortium$335,106
U01 · FY2024 · HL
The Intermountain West-Atlantic Center (InterACT) for the APS Phenotyping Consortium$193,126
U01 · FY2023 · HL
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU$637,032
R01 · FY2022 · NR · contact PI
Nutrition and Exercise in Critical Illness (The NEXIS Trial): A Randomized Trial of Combined Cycle Ergometry and Amino Acids in the ICU$687,902
R01 · FY2021 · HL
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU$648,249
R01 · FY2021 · NR
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment$733,343
R42 · FY2020 · AG
Nutrition and Exercise in Critical Illness (The NEXIS Trial): A Randomized Trial of Combined Cycle Ergometry and Amino Acids in the ICU$709,833
R01 · FY2020 · HL
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU$635,026
R01 · FY2020 · NR
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment$374,498
R42 · FY2020 · AG
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment$795,824
R42 · FY2019 · AG
Nutrition and Exercise in Critical Illness (The NEXIS Trial): A Randomized Trial of Combined Cycle Ergometry and Amino Acids in the ICU$707,635
R01 · FY2019 · HL
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU$603,834
R01 · FY2019 · NR
Nutrition and Exercise in Critical Illness (The NEXIS Trial): A Randomized Trial of Combined Cycle Ergometry and Amino Acids in the ICU$701,294
R01 · FY2018 · HL
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU$677,044
R01 · FY2018 · NR
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment$371,807
R42 · FY2018 · AG
Improving Long-Term Outcomes Clinical Research for Acute Respiratory Failure$1,059,519
R24 · FY2017 · HL · contact PI
Nutrition and Exercise in Critical Illness (The NEXIS Trial): A Randomized Trial of Combined Cycle Ergometry and Amino Acids in the ICU$734,325
R01 · FY2017 · HL
Improving Long-Term Outcomes Clinical Research for Acute Respiratory Failure$1,069,333
R24 · FY2016 · HL · contact PI
Improving Long-Term Outcomes Clinical Research for Acute Respiratory Failure$1,154,707
R24 · FY2015 · HL · contact PI
Discovery and Prediction of Novel Functional Outcome Phenotypes for ARDS$107,578
R21 · FY2015 · HL
Improving Long-Term Outcomes Clinical Research for Acute Respiratory Failure$1,251,140
R24 · FY2014 · HL · contact PI
Discovery and Prediction of Novel Functional Outcome Phenotypes for ARDS$109,217
R21 · FY2014 · HL
Improving Long-Term Outcomes Clinical Research for Acute Respiratory Failure$857,064
R24 · FY2013 · HL · contact PI
ICU-ACQUIRED NEUROMUSCULAR DYSFUNCTION AND OUTCOMES IN ACUTE LUNG INJURY$361,838
R01 · FY2013 · HL
ICU-ACQUIRED NEUROMUSCULAR DYSFUNCTION AND OUTCOMES IN ACUTE LUNG INJURY$371,372
R01 · FY2012 · HL
Improving Long-Term Physical and Mental Health after Acute Lung Injury$767,920
R01 · FY2011 · HL
Patient Outcomes 6 and 12 Months After ALTA, OMEGA and EDEN ARDS Network Trials$386,816
R01 · FY2011 · HL · contact PI
ICU-ACQUIRED NEUROMUSCULAR DYSFUNCTION AND OUTCOMES IN ACUTE LUNG INJURY$377,386
R01 · FY2011 · HL
ICU-ACQUIRED NEUROMUSCULAR DYSFUNCTION AND OUTCOMES IN ACUTE LUNG INJURY$414,777
R01 · FY2010 · HL
Patient Outcomes 6 and 12 Months After ALTA, OMEGA and EDEN ARDS Network Trials$383,459
R01 · FY2010 · HL · contact PI
Patient Outcomes 6 and 12 Months After ALTA, OMEGA and EDEN ARDS Network Trials$405,803
R01 · FY2009 · HL · contact PI
Patient Outcomes 6 and 12 Months After ALTA, OMEGA and EDEN ARDS Network Trials$361,241
R01 · FY2009 · HL · contact PI
Patient Outcomes 6 and 12 Months After ALTA, OMEGA and EDEN ARDS Network Trials$426,072
R01 · FY2008 · HL · contact PI